Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R

Heart Rhythm(2020)10.1016/j.hrthm.2020.09.007Source: DataRank Database

Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R is a research paper published in Heart Rhythm (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.61)OA: greenTopics (54)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Hua Wei ORCID,Yanli Xia ORCID,Martin Morad ORCID,Xiaohua Zhang ORCID

Live enrichment

PubMed:32931925 OpenAlex:https://openalex.org/W3084533221

National Institutes of Health

Grant: 1R56HL147054-01

Functional implications of RyR2 mutations in human cardiomyocytes

FWCI

2.61

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7893824

publisherhttps://api.elsevier.com/content/article/PII:S1547527120308894?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1547527120308894?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.hrthm.2020.09.007

Fields of Study

Cardiac electrophysiology and arrhythmiasCRISPR and Genetic EngineeringNeuroscience and Neural Engineering0301 basic medicine03 medical and health sciences

MeSH Terms

Gene EditingCRISPR-Associated Protein 9Polymorphic Catecholaminergic Ventricular TachycardiaCalciumCell DifferentiationDNADNA Mutational AnalysisHumansMutationPhenotypeSarcoplasmic ReticulumTachycardia, VentricularRyanodine Receptor Calcium Release ChannelCalcium SignalingMyocytes, CardiacInduced Pluripotent Stem CellsClustered Regularly Interspaced Short Palindromic Repeats

Keywords

Ryanodine receptor 2Ryanodine receptorCatecholaminergic polymorphic ventricular tachycardiaCRISPRCell biologyCalcium signalingInduced pluripotent stem cellCalciumHEK 293 cellsBiologyEndoplasmic reticulumSignal transductionGeneticsGeneMedicineInternal medicineEmbryonic stem cellGene EditingDNA Mutational AnalysisInduced Pluripotent Stem CellsCell DifferentiationRyanodine Receptor Calcium Release ChannelDNASarcoplasmic ReticulumPhenotypeCRISPR-Associated Protein 9MutationTachycardia, VentricularHumansClustered Regularly Interspaced Short Palindromic RepeatsMyocytes, CardiacPolymorphic Catecholaminergic Ventricular Tachycardia

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being